trending Market Intelligence /marketintelligence/en/news-insights/trending/jscr2Ao7vL_V-bztryyUCg2 content esgSubNav
In This List

Dishman Carbogen Amcis issues shares as part of amalgamation

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Dishman Carbogen Amcis issues shares as part of amalgamation

The board of Dishman Carbogen Amcis Ltd., issued and allotted 161,394,272 equity shares of 2 Indian rupees each, as fully paid-up equity shares, to the shareholders of Dishman Pharmaceuticals and Chemicals Ltd. as part of the amalgamation of Dishman Pharmaceuticals, Carbogen Amcis (lndia) Ltd. and Dishman Care Ltd.

The shares were allotted in the ratio of 1 share of Dishman Carbogen Amcis for every 1 share held in Dishman Pharmaceuticals to those shareholders of record as of May 31.

The company is executing a corporate action with the National Securities Depository Ltd. and the Central Depository Services (India) Ltd. to credit the equity shares in the shareholders' account.

The new entity will then list said shares with the Bombay Stock Exchange Ltd. and National Stock Exchange of lndia Ltd.

The amalgamation was approved by the High Court of Gujarat, India, on Dec. 16, 2016.

As of June 6, US$1 was equivalent to 64.44 Indian rupees.